Contract award notice
Results of the procurement procedure
Section I: Contracting
authority
I.1) Name and addresses
NHS Blood and Transplant
North Bristol Park
Filton, Bristol
BS34 7QH
UK
Telephone: +44 1179217230
E-mail: Jess.Allen@nhsbt.nhs.uk
NUTS: UK
Internet address(es)
Main address: www.nhsbt.nhs.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Frozen, Non-UK Derived Pathogen Reduced Plasma
II.1.2) Main CPV code
33141570
II.1.3) Type of contract
Supplies
II.1.4) Short description
NHSBT requires pathogen reduced plasma which will then be subsequently manufactured into FFP, Single and pooled cryoprecipitate for paediatric and neonatal use, for recipients born on / after 1.1.1996. Those recipients are deemed not to have been exposed to the risk of vCJD in the UK food chain. Plasma is to be sourced from a TPSG approved (based on SaBTOs 2013 recommendations) country outside the UK with vCJD prevalence >2,5 log lower than the UK.
The Contract commenced on the 8.5.2018, the term of this Contract shall expire 2 years from the end of the Set Up Period and Ramp Up Period 1.12.2018 (estimated). The contract is for a period of 2 years with the option to extend for 2 periods of 12 months.
The estimated value given below is based on 4 years.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
13 200 000.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33141510
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
NHSBT requires pathogen reduced plasma which will then be subsequently manufactured into FFP, Single and pooled cryoprecipitate for paediatric and neonatal use, for recipients born on / after 1.1.1996. Those recipients are deemed not to have been exposed to the risk of vCJD in the UK food chain. Plasma is to be sourced from a TPSG approved (based on SaBTOs 2013 recommendations) country outside the UK with vCJD prevalence >2,5 log lower than the UK.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
08/05/2018
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
MacoPharma Ltd
London
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 13 200 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
NHS Blood and Transplant
Bristol
UK
VI.5) Date of dispatch of this notice
06/06/2018